Company Quick10K Filing
Bristol Myers Squibb
10-Q 2020-06-30 Filed 2020-08-06
10-Q 2020-03-31 Filed 2020-05-07
10-K 2019-12-31 Filed 2020-02-24
10-Q 2019-09-30 Filed 2019-10-31
10-Q 2019-06-30 Filed 2019-07-25
10-Q 2019-03-31 Filed 2019-04-25
10-K 2018-12-31 Filed 2019-02-25
10-Q 2018-09-30 Filed 2018-10-25
10-Q 2018-06-30 Filed 2018-07-26
10-Q 2018-03-31 Filed 2018-04-26
10-K 2017-12-31 Filed 2018-02-13
10-Q 2017-09-30 Filed 2017-10-26
10-Q 2017-06-30 Filed 2017-07-27
10-Q 2017-03-31 Filed 2017-04-27
10-K 2016-12-31 Filed 2017-02-21
10-Q 2016-09-30 Filed 2016-10-27
10-Q 2016-06-30 Filed 2016-07-28
10-Q 2016-03-31 Filed 2016-04-28
10-K 2015-12-31 Filed 2016-02-12
10-Q 2015-09-30 Filed 2015-10-27
10-Q 2015-06-30 Filed 2015-07-23
10-Q 2015-03-31 Filed 2015-04-28
10-K 2014-12-31 Filed 2015-02-13
10-Q 2014-09-30 Filed 2014-10-24
10-Q 2014-06-30 Filed 2014-07-24
10-Q 2014-03-31 Filed 2014-04-29
10-K 2013-12-31 Filed 2014-02-14
10-Q 2013-09-30 Filed 2013-10-23
10-Q 2013-06-30 Filed 2013-07-25
10-Q 2013-03-31 Filed 2013-04-25
10-K 2012-12-31 Filed 2013-02-15
10-Q 2012-09-30 Filed 2012-10-24
10-Q 2012-06-30 Filed 2012-07-25
10-Q 2012-03-31 Filed 2012-04-26
10-K 2011-12-31 Filed 2012-02-17
10-Q 2011-09-30 Filed 2011-10-27
10-Q 2011-06-30 Filed 2011-07-28
10-Q 2011-03-31 Filed 2011-04-28
10-K 2010-12-31 Filed 2011-02-18
10-Q 2010-09-30 Filed 2010-10-26
10-Q 2010-06-30 Filed 2010-07-22
10-Q 2010-03-31 Filed 2010-04-29
10-K 2009-12-31 Filed 2010-02-19
8-K 2020-08-19 Other Events
8-K 2020-08-06 Earnings, Exhibits
8-K 2020-07-29 Officers, Exhibits
8-K 2020-07-16 Other Events, Exhibits
8-K 2020-06-16
8-K 2020-05-19
8-K 2020-05-07
8-K 2020-04-14
8-K 2020-03-25
8-K 2020-03-10
8-K 2020-03-05
8-K 2020-02-20
8-K 2020-02-06
8-K 2019-11-21
8-K 2019-11-20
8-K 2019-11-15
8-K 2019-11-15
8-K 2019-11-12
8-K 2019-11-07
8-K 2019-11-05
8-K 2019-11-01
8-K 2019-10-31
8-K 2019-10-30
8-K 2019-10-18
8-K 2019-10-08
8-K 2019-09-23
8-K 2019-09-11
8-K 2019-08-25
8-K 2019-07-25
8-K 2019-07-01
8-K 2019-06-28
8-K 2019-06-24
8-K 2019-06-05
8-K 2019-05-29
8-K 2019-05-24
8-K 2019-05-16
8-K 2019-05-07
8-K 2019-05-01
8-K 2019-05-01
8-K 2019-05-01
8-K 2019-04-25
8-K 2019-04-17
8-K 2019-04-12
8-K 2019-04-04
8-K 2019-03-25
8-K 2019-03-08
8-K 2019-03-08
8-K 2019-01-25
8-K 2019-01-24
8-K 2019-01-18
8-K 2019-01-03
8-K 2019-01-02
8-K 2018-12-19
8-K 2018-10-25
8-K 2018-09-14
8-K 2018-08-27
8-K 2018-07-26
8-K 2018-07-17
8-K 2018-05-01
8-K 2018-04-26
8-K 2018-03-01
8-K 2018-02-14
8-K 2018-02-05
8-K 2018-01-22
8-K 2018-01-05

Bristol Myers Squibb Financials

BMY Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Abbott (ABT) 150,169 59% 16.4 5% 67,887 36,586 31,904 18,673 3,687 10,019 164,168
AbbVie (ABBV) 109,786 77% 21.1 5% 59,441 67,667 32,867 25,412 3,255 6,259 132,264
Eli Lilly (LLY) 105,897 78% 12.7 21% 37,893 34,431 22,644 17,612 7,948 9,419 119,560
Beigene (BGNE) 100,124 74% -123.1 -44% 1,881 587 430 318 -827 -807 99,328
Bristol Myers Squibb (BMY) 82,160 70% 10.6 10% 57,433 39,679 24,173 16,837 5,680 7,151 76,061
Celgene (CELG) 72,111 96% 10.4 14% 41,363 29,276 16,982 16,354 5,880 7,734 80,796
Zoetis (ZTS) 60,799 51% 29.1 13% 11,272 8,594 6,150 3,124 1,461 2,252 65,484
Allergan (AGN) 54,957 63% -241.2 -5% 122,925 38,486 15,818 9,949 -5,872 -316 76,270
Sanofi (SNY) 52,845 0% 111,408 0 0 0 0 52,184
GW Pharmaceuticals (GWPH) 45,954 89% -870.1 -8% 848 128 205 182 -64 -52 45,400
Vertex Pharmaceuticals (VRTX) 43,431 87% 46.7 29% 7,515 2,261 3,620 3,135 2,144 857 40,027
Regeneron Pharmaceuticals (REGN) 32,266 0% 12.2 15% 13,939 3,435 7,622 0 2,144 2,539 30,869
Alexion Pharmaceuticals (ALXN) 23,581 92% 12.8 10% 14,815 4,448 4,736 4,359 1,470 1,874 23,912
Biomarin Pharmaceutical (BMRN) 12,700 79% 1,194.1 -1% 4,558 1,484 1,250 986 -39 11 13,147
Mylan (MYL) 10,768 34% 12.5 -0% 31,054 19,590 8,309 2,810 -4 1,882 23,458
Elanco Animal Health (ELAN) 9,964 52% 30.6 1% 8,824 3,336 3,083 1,611 94 393 12,004
Alnylam Pharmaceuticals (ALNY) 8,913 80% -9.7 -32% 2,542 935 169 135 -821 -820 7,987
Ionis Pharmaceuticals (IONS) 8,784 76% 17.4 15% 2,895 1,397 821 626 436 491 8,536
Bausch (BHC) 7,760 0% 25.3 -1% 31,667 29,107 8,498 0 -266 1,216 30,774
Jazz Pharmaceuticals (JAZZ) 7,549 21% 11.2 11% 5,528 2,473 2,056 441 609 762 8,530

Balance Sheet ($MM)2009-12-312010-03-312010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash7,6835,1355,9187,5815,0333,4053,6654,4715,7762,3072,8011,5031,6561,3551,8211,7713,5865,2254,2824,8515,5716,2944,1993,9752,3852,6442,9343,4324,2373,9103,4704,6445,4215,3424,9995,4086,9117,33528,40430,489
Accounts Receivable1,8051,9651,9852,0462,1162,1812,2502,2511,6231,7341,7081,7981,8511,8391,6901,7421,7991,8232,1002,2502,5432,7142,9483,3633,6853,8133,7744,0834,2194,3324,3474,3744,3234,6224,6364,5944,5034,289
Inventory1,4131,2841,2651,3691,2041,3221,4921,3571,3841,4631,5211,6971,6571,7911,7851,6401,4981,6551,6661,5651,5601,4371,3041,1301,2211,3361,4371,4821,2411,3841,2171,2501,1661,2311,2421,2821,1951,2831,3081,192
PP&E5,0554,8228,2288,2858,2608,3208,3438,2958,3818,4458,4019,2829,3839,3739,3939,5148,8438,8568,9368,9629,0668,9909,1548,4678,6318,7578,9468,9319,1739,3219,1169,2658,9879,1599,1119,1768,8458,9118,6948,787
Assets31,00830,75331,05131,88531,07630,85131,83332,01432,97032,40831,66736,04435,89735,95836,25236,80438,59233,42433,50333,45033,74933,57931,95431,77931,74831,89232,83133,72733,70732,93733,40933,97733,55133,08332,64133,73434,98634,83455,16357,433
Accounts Payable1,7111,7521,6811,7251,9832,0362,4012,2922,6032,3852,1342,0852,2022,0792,3462,4662,5592,5022,4052,5682,4872,3461,8391,2491,5651,5431,5041,4071,6641,5031,5511,6992,2481,7251,8731,7731,8921,9762,0051,888
Long-Term Debt6,1306,0816,2486,4795,3285,2765,3325,4375,3765,2705,2097,2277,2327,1807,1226,5627,9817,3677,3727,2677,2427,1276,6156,6326,5506,5936,5816,5856,4657,9867,6616,9826,9757,0206,9326,9346,8955,63524,43324,390
Liabilities16,22315,52015,47716,02815,43814,95015,68815,57817,10316,16215,85522,14422,25922,25921,87922,09023,35617,89318,12418,24918,76617,89016,66316,50617,32417,34117,75317,94617,36018,40218,58819,06321,70420,17720,22319,98420,85919,51739,01239,679
Stockholders' Equity14,84315,24915,66815,97015,71315,99816,35316,57215,95616,33716,09813,90013,62313,65914,37114,72615,15415,47315,32715,14314,85215,54615,12315,07914,26614,38614,91815,61316,17714,41614,69914,78311,74112,79312,31713,64014,03115,21816,04917,648
Income Statement ($MM)2009-12-312010-03-312010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue4,8074,7684,7985,1115,0115,6475,3455,4545,2514,4433,7364,1913,8314,0484,0654,4413,8113,8893,9214,2584,0414,1634,0694,2874,3914,8714,9225,2434,9295,1445,2545,4495,1935,7045,6915,9735,9206,2736,007
Cost of Revenue1,4141,3671,0751,2739669521,3831,6731,6901,8441,9921,810
Gross Profit3,6974,0873,1163,1683,2923,3353,8603,7764,2834,0764,2814,197
R&D9108228241,0109351,0349731,0089099629511,0829309518939579461,4169831,1891,0161,8561,1321,9161,1361,2661,1381,4001,2881,6591,5431,9211,2502,4351,2801,3511,3281,382
SG&A9008948921,0009281,0761,0191,2161,0021,0041,0711,1439941,0429801,0689579511,0291,1518949689831,9961,0681,2381,1441,4611,0741,1671,1471,2999801,1311,1041,0061,0761,055
Tax351324312571400571475363545321-546-4115159712613449114276-87249162257-2224494273441884293733273,027284135255264337-17
Net Income1,1011,2681,3024831,3671,3071,3558521,482808-711925623536692735937334732271,199-110730-1881,2061,1881,2158981,574922856-2,3281,4953821,9121,1601,7151,4391,366
Cash Flow ($MM)2009-12-312010-03-312010-06-302010-09-302010-12-312011-03-312011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating4641,0491,3831,5954811,0931,6981,5683871,1344,584836-4281,5101,0531,4106171,05690357262671524611-3864111,3971,4288611,5841,7131,1171,1751,0571,2791,3902,0832,556
Cash Investing-2,519238948-2,479-1,437-332-163495-3,027226-4,20327716157-475-3152,212-1,511164351754-1,280-62-9841,426406-36816-203-1,0241421,019-43-348-1471,060715491
Cash Financing-486-495-698-1,664-692-507-704-754-836-850-1,689-958-44-1,115-620711-1,192-486-528-231-682-883-700-1,086-792-524-539-590-1,013-1,006-706-1,352-1,222-1,015-720-2,02918,268-941